Government’s investment of 1.3 billion to boost API manufacturing in India

A turnaround strategy to reduce India’s dependence on China

0
113

Following the news that the Indian Government has approved US$ 1.3 billion (approximately Rs 1000 crore) healthcare package to boost the domestic manufacturing of active pharmaceutical ingredients (API), according to Global data report. Prashant Khadayate, pharma analyst at GlobalData, offers his view, “The package, which is part of a turnaround…

Choose your subscription to read more

Trial

0 /mo
Not sure which package to choose? Try full access
  • ₹ 0 for 4 weeks*

PSA Plan 1

1000 /year
Access to the website, weekly eMail newsletter
  • ₹1,000.00 for 1 year*

PSA Plan 2

1500 /Year
Access to the website, weekly eMail newsletter and monthly eMag
  • ₹1500 for Year*

PSA Plan 3

2000 /Year
Print Copy, access to the website, weekly eMail newsletter and monthly eMag
  • ₹2,000.00 for 1 year*